Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (T1D) (R01)

קרןNational Institute of Diabetes and Digestive and Kidney Diseases/NIH
סוגResearch Grants
תאריך אחרון10/05/2018
פקולטהEngineering, Exact Sciences, Life Sciences, Medicine

This grant encourages applications from institutions/organizations proposing original research addressing barriers that limit progress toward effective cell replacement therapies for type 1 diabetes (T1D). The purpose is to support research leading to the development and testing of novel and supportive technologies for the improvement of cell replacement interventions using novel biomaterials and devices for T1D treatment

Funding: $500,000 per year 

Duration: 4 years 


Research Authority due date: 27.3.18

LOI (encouraged) due date: 10.4.18

Full application due date: 10.5.18

קבצים מצורפים
עדכון אחרוןעדכון אחרון: 18/02/2018
אוניברסיטת תל-אביב, ת.ד. 39040, תל-אביב 6997801
UI/UX Basch_Interactive